J2J-MC-JZLB - ClinicalTrials.gov - NCT04647487
J2J-MC-JZLB - ClinicalTrials.gov - NCT04647487
Key Requirements
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must have estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) breast cancer
Participants must be able to swallow capsules
Participants must be willing to be available for the duration of the study and are willing to follow study procedures
Participants must NOT
Participants must not be pregnant or breastfeeding
Participants must not plan to receive other treatment for breast cancer during study
Participants must not have major surgery within 28 days of starting study treatment
Trial Summary
Conditions the trial is for
Breast Cancer
What the trial is testing?
LY3484356
Could I receive a Placebo?
no
Enrollment Goal
60
Trial Dates
January 2021 - March 2022
Trial Phase
1
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must have estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) breast cancer
Participants must be able to swallow capsules
Participants must be willing to be available for the duration of the study and are willing to follow study procedures
Participants must NOT
Participants must not be pregnant or breastfeeding
Participants must not plan to receive other treatment for breast cancer during study
Participants must not have major surgery within 28 days of starting study treatment
Trial Summary
Conditions the trial is for
Breast Cancer
What the trial is testing?
LY3484356
Could I receive a Placebo?
no
Enrollment Goal
60
Trial Dates
January 2021 - March 2022
Trial Phase
1
Trial Locations
Hide locations not currently recruiting